PERVASIP CORP NEW - PVSP STOCK NEWS

Pervasip Corp. (OTCPK: PVSP) announced a significant reduction of 2 billion in authorized shares to combat stock manipulation and enhance shareholder value. CEO German Burtscher emphasized that this move aims to minimize shareholder dilution while retaining sufficient shares for future capital-raising efforts. Additionally, Pervasip confirmed it would not consider reverse splits for five years, except for a potential uplisting to OTCQX. The company remains committed to completing audits and restructuring to generate value for shareholders, as well as its involvement in the cannabis industry.

Pervasip Corp. (OTCPK: PVSP) announced its unaudited financial results for Q2 2022, reporting a decrease in revenue to $3.68 million from $4.38 million in Q2 2021 due to an 18% market contraction. The CEO highlighted a strategic move to capture market share by lowering prices and increasing wholesale sales, despite a net loss of $(433,279). The company plans to launch a new craft brand and anticipates $10-12 million in annualized sales from new products. With restructuring efforts, Pervasip forecasts improved performance in Q3 and Q4, projecting annualized revenues of $21 million.

Pervasip Corp. (OTC: PVSP) announced a strategic partnership with Zen Asset Management to develop concentrates brands, including Dabs4Less and Vape4Less, for distribution in Washington State. The Washington vape and concentrates market is valued at $380 million, presenting significant opportunities. The new brands aim for monthly sales of $700,000, totaling $8.4 million annually. With Artizen’s distribution channels and independent cultivators, the partnership anticipates additional product rollouts in late 2022, potentially driving annual revenues toward $12 million for Artizen.

Pervasip Corp. (OTC: PVSP) announced a joint venture with KRTL Biotech to launch Artizen Wellness, focusing on wellness and nutritional products. This venture aims to capitalize on the $1 trillion global wellness market, emphasizing natural compounds for mood and mental health. Pervasip's CEO highlighted the expertise of their team, which includes leading professionals in cannabinoid-based products. KRTL’s CEO emphasized the alignment of their mission with high product standards. Future personnel announcements are expected as the venture progresses.

Pervasip Corp. (OTC: PVSP) announced on June 30, 2022, that its partnership with Full Spectrum Advisors is delivering results that surpass expectations. The company reports a 25% increase in harvest yields from its Artizen flower cultivation centers, with upgrades still at 40% completion. President & CEO German Burtscher highlighted improved genetic diversity and updated cultivation practices as key contributors to enhanced flower quality and yield. Pervasip aims to achieve an additional $5 million in annual revenue as a result of these advancements.

Pervasip Corp. (OTC: PVSP) announced its partnership with Artizen Corp. and Dr. Kyeung-Il Park from Yeungnam University to develop the indoor smart growing sector for the Korean Hemp development project. This initiative, supported by the Hemp Regulation Free Special Zone Project Promotion Team, aims to advance the Korean CBD industry. With Korea committing $40 million for greenhouse trials and research, Pervasip views this as a significant step toward establishing wellness products in Asia. CEO German Burtscher emphasizes the strategic importance of this collaboration.

Pervasip Corp. (OTC: PVSP) will present at the Emerging Growth Conference on June 22, 2022, at 11:00 AM Eastern Time. This live online event provides an opportunity for shareholders and investors to interact with CEO German Burtscher. The presentation will last 30 minutes and will allow for a Q&A session afterwards. For those unable to attend live, an archived webcast will be available post-event. Pervasip focuses on developing companies in high-value emerging markets, including the cannabis industry through its subsidiary, Artizen Corporation.

Pervasip Corp. (OTCPK: PVSP) has announced a strategic partnership with Freedom Cannabis to explore collaborative business opportunities, including co-branding and intellectual property sharing. This relationship aims to enhance Artizen's presence in the U.S. cannabis market, leveraging Freedom's strong foundation. The non-binding Letter of Intent also opens doors for a potential joint venture and future merger, pending regulatory approvals. Both companies aim to increase brand awareness and market share across North America.

Pervasip Corp. (OTC: PVSP) will present at the Emerging Growth Conference on April 27, 2022. This interactive online event invites investors to engage with CEO German Burtscher during a 30-minute presentation at 1:00 PM Eastern Time. Participants will have the chance to ask questions. An archived webcast will be available for those unable to attend live. Pervasip focuses on high-value emerging markets, particularly within the cannabis industry, through subsidiaries like Artizen Corporation.